These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20385969)

  • 21. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
    Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
    Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profiles for steroidogenic enzymes in adrenocortical disease.
    Bassett MH; Mayhew B; Rehman K; White PC; Mantero F; Arnaldi G; Stewart PM; Bujalska I; Rainey WE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5446-55. PubMed ID: 15985477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
    Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
    Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
    Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui WO; Zedenius J
    Eur J Endocrinol; 2014 Apr; 170(4):583-91. PubMed ID: 24446485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways.
    Sackmann S; Lichtenauer U; Shapiro I; Reincke M; Beuschlein F
    Horm Metab Res; 2011 Feb; 43(2):106-11. PubMed ID: 21249615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells.
    Krug AW; Vleugels K; Schinner S; Lamounier-Zepter V; Ziegler CG; Bornstein SR; Ehrhart-Bornstein M
    Int J Obes (Lond); 2007 Oct; 31(10):1605-16. PubMed ID: 17452987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH.
    He J; Cao Y; Su T; Jiang Y; Jiang L; Zhou W; Zhang C; Wang W; Ning G
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):581-9. PubMed ID: 25944465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas.
    Sarkar D; Imai T; Kambe F; Shibata A; Ohmori S; Siddiq A; Hayasaka S; Funahashi H; Seo H
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5130-7. PubMed ID: 11701665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.
    Lichtenauer UD; Shapiro I; Osswald A; Meurer S; Kulle A; Reincke M; Riepe F; Beuschlein F
    Horm Metab Res; 2013 Feb; 45(2):124-9. PubMed ID: 23111829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid profile in an adrenocortical carcinoma producing aldosterone.
    Müssig K; Wehrmann M; Horger M; Teichmann R; Maser-Gluth C; Häring HU; Overkamp D
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):236-40. PubMed ID: 15891961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
    Gröndal S; Grimelius L; Thorén M; Hamberger B
    Eur J Surg; 1991 Mar; 157(3):179-83. PubMed ID: 1678626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
    Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
    Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of adrenal genes regulated in a potassium-dependent manner.
    Dierks A; Lichtenauer UD; Sackmann S; Spyroglou A; Shapiro I; Geyer M; Manonopoulou J; Reincke M; Hantel C; Beuschlein F
    J Mol Endocrinol; 2010 Oct; 45(4):193-206. PubMed ID: 20647392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
    Heinze B; Fuss CT; Mulatero P; Beuschlein F; Reincke M; Mustafa M; Schirbel A; Deutschbein T; Williams TA; Rhayem Y; Quinkler M; Rayes N; Monticone S; Wild V; Gomez-Sanchez CE; Reis AC; Petersenn S; Wester HJ; Kropf S; Fassnacht M; Lang K; Herrmann K; Buck AK; Bluemel C; Hahner S
    Hypertension; 2018 Feb; 71(2):317-325. PubMed ID: 29279316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of TLR4 and CD14 expression and signaling in human adrenocortical tumors.
    Kanczkowski W; Tymoszuk P; Ehrhart-Bornstein M; Wirth MP; Zacharowski K; Bornstein SR
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E421-9. PubMed ID: 20826579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperaldosteronism due to adrenocortical carcinoma 12 years after surgical removal of an aldosterone-producing adrenocortical adenoma.
    Boers GH; Bogman MJ; Debruyne FM; Hoefnagels WH; Kloppenborg PW; Drayer JI
    Neth J Med; 1981; 24(5):185-9. PubMed ID: 7300996
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
    Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
    Berthon A; Drelon C; Ragazzon B; Boulkroun S; Tissier F; Amar L; Samson-Couterie B; Zennaro MC; Plouin PF; Skah S; Plateroti M; Lefèbvre H; Sahut-Barnola I; Batisse-Lignier M; Assié G; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P
    Hum Mol Genet; 2014 Feb; 23(4):889-905. PubMed ID: 24087794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.